299 related articles for article (PubMed ID: 8194016)
1. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
Araki K; Harada K; Nakamoto K; Shiroma M; Miyakuni T
Clin Exp Immunol; 2000 Feb; 119(2):259-63. PubMed ID: 10632660
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of soluble interleukin-2 receptors in HTLV-I--associated myelopathy.
Yamaguchi K; Nishimura Y; Kiyokawa T; Takatsuki K
J Lab Clin Med; 1989 Oct; 114(4):407-10. PubMed ID: 2794753
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease.
Yasuda N; Lai PK; Ip SH; Kung PC; Hinuma Y; Matsuoka M; Hattori T; Takatsuki K; Purtilo DT
Blood; 1988 Apr; 71(4):1021-6. PubMed ID: 2895675
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.
Motoi T; Uchiyama T; Uchino H; Ueda R; Araki K
Jpn J Cancer Res; 1988 May; 79(5):593-9. PubMed ID: 2900231
[TBL] [Abstract][Full Text] [Related]
6. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.
Yonekura K; Utsunomiya A; Seto M; Takatsuka Y; Takeuchi S; Tokunaga M; Kubota A; Takeda K; Kanzaki T; Uchida Y; Kawai K; Kanekura T
J Dermatol; 2015 Dec; 42(12):1143-8. PubMed ID: 26134467
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
8. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
[TBL] [Abstract][Full Text] [Related]
11. Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma.
Katsuya H; Shimokawa M; Ishitsuka K; Kawai K; Amano M; Utsunomiya A; Hino R; Hanada S; Jo T; Tsukasaki K; Moriuchi Y; Sueoka E; Yoshida S; Suzushima H; Miyahara M; Yamashita K; Eto T; Suzumiya J; Tamura K
Blood; 2017 Jul; 130(1):39-47. PubMed ID: 28515095
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
13. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.
Ikeda S; Momita S; Kinoshita K; Kamihira S; Moriuchi Y; Tsukasaki K; Ito M; Kanda T; Moriuchi R; Nakamura T
Blood; 1993 Oct; 82(7):2017-24. PubMed ID: 8400254
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
[TBL] [Abstract][Full Text] [Related]
17. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
[TBL] [Abstract][Full Text] [Related]
18. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
20. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
Wasik MA; Vonderheid EC; Bigler RD; Marti R; Lessin SR; Polansky M; Kadin ME
Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]